LyondellBasell Posts $2.32 Q3 EPS, $1.4B EBITDA; Sells Houston Refinery for $320.5M
LYB sits 57% above its 52-week low of $41.58.
Summary
LyondellBasell earned $758 million ($2.32 per share) in Q3 2026 versus a year-ago loss, on $1.4 billion of EBITDA, and agreed to sell its idled Houston refinery to Valero for $320.5 million.
Key Events · Earnings and Guidance · LYB
-
Q3 Earnings Swing to Profit
Net income of $758 million, or $2.32 per diluted share, versus a $890 million loss in Q3 2025; sales and other operating revenues were $8,499 million.
-
EBITDA and Segment Mix
EBITDA of $1.4 billion ($1.5 billion excluding identified items). Intermediates & Derivatives EBITDA rose to $720 million from $377 million in Q2 on oxyfuels, while O&P Americas fell to $641 million from $1,183 million on softer polymer and olefin prices.
-
Houston Refinery Sold to Valero
Agreement dated October 29, 2026 to sell Houston Refining, L.P. and the former refinery site to a Valero subsidiary for $320.5 million; closing expected in Q4 2026 subject to regulatory and customary conditions.
-
Balance Sheet and Liquidity
Cash and liquid investments of $3.2 billion and total liquidity of $7,685 million at September 30, 2026, after repaying the €500 million note in September; $224 million of dividends paid and no share repurchases in the quarter.
Analysis · LYB · Industrial Applications And Services
A $758 million profit ($2.32 per diluted share) replaced a $890 million loss a year earlier, with EBITDA of $1.4 billion, or $1.5 billion excluding identified items. Oxyfuels and Intermediates & Derivatives drove the quarter, where EBITDA rose to $720 million from $377 million in Q2, while Olefins & Polyolefins Americas EBITDA fell to $641 million from $1,183 million as polymer and olefin prices softened. Cash rose about $600 million to $3.2 billion, and total liquidity stands at $7.7 billion after a planned €500 million note repayment. Separately, the company agreed on October 29 to sell the shuttered Houston refinery site to a Valero subsidiary for $320.5 million, expected to close in Q4 2026 — a modest cleanup of a non-operating asset rather than a change to the core chemicals business. Guidance for Q4 operating rates (85% North America O&P, 60% Europe O&P, 75% I&D) points to a seasonally softer quarter.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LYB was trading at $65.19 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.1B. The 52-week trading range was $41.58 to $83.94. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.